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It is well known that the fetal ethanol exposure and prenatal stress may have adverse effects on brain development. Interestingly, some 
morphological and functional recovery from their teratogenic effects that take place during brain maturation. However, mechanisms 
that underlie this recovery are not fully elucidated. The aim of this study was to examine whether the postnatal attenuation of 
fetal alcohol – and maternal stress‑induced morphological and functional deficits correlates with compensatory changes in the 
expression/activation of the brain proteins involved in inflammation, cell survival and apoptosis. In this project, we investigated the 
hippocampus which belongs to the brain regions most susceptible to the adverse effects of prenatal ethanol exposure. Pregnant rat 
dams were administered ethanol (A) or isocaloric glucose solution (IC) by a gastric intubation during gestational days 7‑20. The pure 
control group received ad libitum laboratory chow and water with no other treatment. The hippocampi of fetal‑ethanol and control 
pups were examined at the postnatal day (PD)1, PD10, PD30 and PD60. Moderate fetal‑ethanol exposure and prenatal intubation 
stress caused a significant increase in molecular factors relating to inflammation (iNOS) and cell survival/apoptosis pathways (PTEN, 
GSK‑3 and ERK) at birth, with a rapid compensation from these developmental deficits upon removal of alcohol at PD10. Indeed, an 
increase in ERK1/2 and JNK1/2 activation at PD30 was observed with ethanol consumption. It indicates that the recovery process in A 
and IC brains started soon after the birth upon the ethanol and stressor withdrawal and continued until the adulthood.
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INTRODUCTION
Ethyl alcohol (ethanol) is a well‑known teratogen 
that impairs brain development (Ward and Wainwright, 
1989; Miller and Montgomery, 1992; Michaelis and Mi‑
chaelis, 1994). The cells in the central nervous system 
are highly vulnerable to adverse effects of ethanol 
and fetal ethanol exposure may cause a massive wave 
of apoptotic neurodegeneration in many different re‑
gions of the developing human brain. (Ikonomidou et 
al., 2000; Light et al., 2002; Goodlett et al., 2005). The 
neocortex, hippocampus and cerebellum are especially 
sensitive to ethanol exposure (Tran and Kelly, 2003).
The ethanol‑associated neuronal damage which is 
initiated by activation of the mitochondrial apoptotic 
pathway (Cartwright et al., 1998; Ikonomidou et al., 2000; 
Light et al., 2002; Ramachandran et al., 2003; Dikranian 
et al., 2005) may be related to several molecular mecha‑
nisms including induction of oxidative stress, activation 
of caspase‑3, functional loss of neurotrophic factors and 
inhibition of survival factors (Kotch et al., 1995, Goodlett 
et al., 2005, Young et al., 2005, Ieraci and Herrera, 2007). 
Furthermore, in the developing brain, NMDA and GABAA 
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receptors play an important role in the appearance of the 
toxic effects of ethanol via apoptotic neurodegeneration 
(Costa et al., 2000; Hsiao et al., 2002; Nixon et al., 2004). 
Prenatal ethanol consumption reduces the concentra‑
tion of brain‑derived neurotrophic factor (BDNF) and 
alters its receptor, TrkB, which attenuates the function 
of intracellular cell survival signaling pathways such as 
MAPK/ERK and PI3‑K/Akt (Guerri, 2002). Additionally, 
ethanol‑related conditions might change the ratio of 
pro‑apoptotic and anti‑apoptotic proteins in a manner 
favoring cell death and make the developing brain more 
prone to neurodegeneration (de la Monte et al., 2000; 
Olney et al., 2002; Heaton et al., 2003).
In our previous investigation (Elibol‑Can et al., 2014a), 
we observed behavioral deficits in fetal‑ethanol juveniles 
(postnatal day (PD) 30) when compared to age‑matched 
controls and to fetal‑ethanol adult subjects (PD60), sug‑
gesting a functional recovery occurring with maturation 
in fetal‑alcohol rats. Also, in this previous study, after 
a moderate prenatal intoxication with ethanol, a margin‑
ally lower number of granule cells was estimated in den‑
tate gyrus (DG) on PD30, which correlated with a trend to‑
wards a lower number of DCX‑immunoreactive neurons in 
the subgranular zone at PD10. Additionally, these changes 
were ameliorated in the adult subjects by the age of PD60. 
At the morphological level, moderate levels of fetal etha‑
nol and the maternal intubation stress during gestation, 
resulted in a smaller soma size in granule cells, reduced 
dendritic parameters and lower spine density in pyramidal 
neurons which however was recorded at birth only with 
full recovery from these effects within the first 10 post‑
natal days (Jakubowska‑Doğru et al., 2017). Our results 
suggest a fetal ethanol‑ and/or maternal stress‑ induced 
developmental delay rather than a permanent damage. 
Therefore, the results directed us toward the investigation 
of the regenerative capacity of young brain, specifical‑
ly regarding protein changes related to cell survival and 
apoptosis. In addition, we intended to look deeper into the 
potential molecular correlates of developmental deficits 
and/or delays and potential compensatory processes after 
fetal ethanol exposure. To do so in the rat model, we ex‑
amined hippocampal expression and activation of selected 
proteins related to cell survival, apoptosis and inflamma‑
tion, which lack through investigation as related to pre‑
natal ethanol exposure, over a protracted developmental 
period from birth to the adulthood, for the first time.
METHODS
Subjects
Adult (3‑4 months old), naive, female (n=25) and 
male (n=15) Wistar rats, obtained from the Animal 
Breeding Facility of the Gülhane Military Medical Acad‑
emy (Ankara), were initially used in the present study. 
The animals’ care conditions during breeding and rear‑
ing were the same as in our previous studies (Dursun 
et al., 2006; Elibol‑Can et al., 2014a, 2014b; Jakubows‑
ka‑Doğru et al., 2017). Rats were mated and appearance 
of a vaginal plug was considered evidence of a success‑
ful fertilization. This day was marked as the gestation‑
al day 0 (GD0). On GD7, pregnant dams were assigned 
(counterbalanced for initial body mass) to one of three 
treatment groups: alcohol (A) group (n=10), intubated 
control (IC) group (n=8) and intact control (C) group 
(n=7). All experimental procedures were approved by 
the Committee for Animal Research Ethics in Middle 
East Technical University and all applicable interna‑
tional, national and/or institutional guidelines for the 
care and use of animals were followed.
Ethanol Treatment
The dams from the ethanol‑exposed (A group) were 
administered ethanol (96.5% v/v, Merck) at 6 g/kg of 
body mass, daily from GD7 to GD20 (Dursun et al., 2006; 
Elibol‑Can et al., 2014a). Ethanol was diluted in 2‑3 ml 
of water according to body mass and administered in 
two equal doses one‑hour apart by intragastric intuba‑
tions using a stainless curved feeding needle (18 ga, 3 
in; Stoelting Co., Wood Dale, IL). The IC group received 
the same volume of fluid with sucrose substituted iso‑
calorically for ethanol. In addition, to minimize differ‑
ences in the food intake between the ethanol exposed 
group and control group, we provided the same amount 
of food to the IC group, which was calculated by de‑
termining the weight of food consumed on the previ‑
ous day by group A females. The C group received ad 
libitum laboratory chow and water with no additional 
treatment. The protocol for ethanol treatment was de‑
scribed previously (Dursun et al., 2006). On GD20, the 
mean blood ethanol concentration in the pregnant rats 
from the A group which was estimated 3h after the 
second intubation by gas chromatography‑mass spec‑
trometry (GC‑MS) was 246.6±40.9 mg/dl.
Pups
Male pups from each treatment group were random‑
ly assigned to four age subgroups (n=7 for each treat‑
ment group) and euthanized at PD1 (n=21), PD10 (n=21), 
PD30 (n=21) and PD60 (n=21). The rats from each age 
group were intermixed between litters by assigning 
one or two pups from a single litter to each of the age 
groups in order to limit the effect of litter differences.
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Western blotting 
The rats were euthanized by decapitation and 
their right hippocampi were dissected. Protein ex‑
traction was performed by homogenizing the hippo‑
campi with lysis buffer in the presence of protease 
and phosphatase inhibitors. Tissue samples were 
centrifuged at 14000 rpm for 20 min at 40C, and then 
supernatants were collected. After that, the hippo‑
campal tissues were pooled by taking equal amounts 
of supernatant from each animal in the same group 
(Kil ic et al., 2017). Protein concentrations were de‑
termined by a BCA assay kit in the Multiskan™ GO 
Microplate Spectrophotometer (Thermo Fisher Sci‑
entific; Paisley, England). Sample proteins were sep‑
arated by sodium dodecyl sulphate‑polyacrylamide 
gel electrophoresis (SDS‑PAGE) (Biorad; Hercules, 
USA) and subsequently transferred to polyvinyl flu‑
oride (PVDF) membranes. Then, blots on the mem‑
brane were washed with Tris buffered saline and in‑
cubated with blocking solution (2% Blocking Reagent 
in Tris Buffered Saline) for 1 h at room temperature. 
Afterwards, the blots were incubated with prima‑
ry antibodies; nNOS, iNOS, Hsp70, mTOR, Bax, Bcl2, 
Bcl‑XL, PARP, PTEN, AKT, GSK3, ERK, JNK, and CREB 
overnight at 4°C and on the following day, with sec‑
ondary antibodies (1:5000, HRP‑linked anti‑rabbit or 
anti‑mouse IgG, Cell Signaling; Danvers, USA) for 1 h 
at room temperature. Blots were incubated with sub‑
strate solution by chemiluminescence labeling for 
visualization. Protein loading was controlled using 
β‑tubulin antibody. At least three independent blots 
were performed to measure the expression of each 
protein. Immunoreactive protein bands were quanti‑
fied densitometrically using ImageJ analysis system 
(NIH; Washington, USA).
Statistical analysis
Group means ± SEM were calculated for all of the 
measurements. A repeated‑measures analysis of vari‑
ance (ANOVA) was conducted on dam body mass data 
for GD7–20. Additionally, between‑group differences 
in pup body mass were analyzed by one‑way ANOVA 
using treatment as an independent factor for each 
age. Two‑way ANOVA (treatment X age) was conduct‑
ed to evaluate the main effects of age and treatment 
as well as age X treatment interaction. Following 
two‑way ANOVA, the post hoc comparisons for multi‑
ple testing were conducted using Fisher’s Least Sig‑
nificant Difference (LSD) test. The SPSS 15 statistical 
package was used for statistical analysis of the data. 
The criterion of statistical significance was P≤0.05.
RESULTS
In all experimental groups, an increase in dam 
body mass was observed throughout the gestational 
period. The repeated measure ANOVA showed a highly 
significant day effect (F(10;140)=50.805, P≤0.001) and in‑
significant treatment X day interaction (F(20;140)=1.234, 
P=0.236). There was no significant difference in dam’s 
body mass between groups except for GD7 and GD8 
(Fig. 1A). Gestational exposure to ethanol decreased 
the body mass of pups at birth (F(2;24)=56.332, P≤0.001) 
and PD10 (F(2;25)=31.602, P≤0.001). Pups in the IC group 
also had lower body mass at PD1 and PD10 (P≤0.05). 
This difference in the body masses disappeared at 
PD30 (Fig. 1B).
The present study investigated the effects of pre‑
natal ethanol exposure on levels of proteins related 
to inflammation (iNOS, nNOS and Hsp70), apoptosis 
Fig. 1. Changes in the mean body masses of dams throughout the GD7‑20 (A) and their offsprings at different postnatal ages (B) from C group, IC group 
and A group. The degree of significance was denoted as * for P≤0.05. Error bars indicate standard error of mean (SEM).
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(Bcl2, Bax, Bcl‑XL, and PARP) and cell survival (mTOR, 
PTEN, JNK, ERK, GSK, CREB and AKT).
In all treatment groups, two‑way ANOVA (treatment 
X age) for iNOS protein levels showed a significant 
main effect of age (F(3;35)=73.320, P<0.001) and a margin‑
ally significant main effect of treatment (F(2;35)=3.150, 
P=0.061) with a significant age X treatment interac‑
tion (F(6;35)=16.047, P<0.001). Post hoc analysis confirmed 
a significant increase in iNOS expression between 
PD10–PD30 (P<0.001) and a significant decrease be‑
tween PD30‑PD60 (P≤0.001) during normal development 
(Table I). At PD1, the level of iNOS protein was higher in 
the A group compared to control groups (P=0.030 for IC 
and P=0.008 for C) and, in both intubated groups (A and 
IC), it was lower at PD30 (P≤0.001) and higher at PD60 
(P≤0.01) compared to C group (Fig. 2A).
In all three treatment groups, the results of two‑way 
ANOVA for nNOS expression confirmed a significant 
main effect of age (F(3;35)=32.615, P<0.001) with insignif‑
icant main effect of treatment and age X treatment in‑
teraction. According to post hoc analysis, there was an 
increase in nNOS levels during the PD30‑PD60 period 
in all groups (P<0.01) (Table I). At PD30, nNOS expres‑
sion was significantly higher in the IC group compared 
to the C group (P=0.028) and the A group (P=0.023) 
(Fig. 2B). 
As estimated by a two‑way ANOVA, the main effect 
of age (F(3;35)=215.362, P<0.001), the main effect of treat‑
ment (F(2;35)=2.944, P=0.072) and an age X treatment in‑
teraction (F(6;35)=6.866, P<0.001) were also significant for 
Hsp70 expression. Post hoc analysis showed that, in all 
groups, it was observed a significant increase between 
PD10–PD30 (P≤0.001) and a significant decrease be‑
tween PD30‑PD60 (P≤0.01) in the hippocampal Hsp70 
concentration (Table I). A significant treatment effect 
was observed at PD10 and at PD30. At PD10, the level 
of Hsp70 protein was higher in the IC group as com‑
pared to both A group (P=0.038) and C group (P=0.008). 
At PD30, the level of Hsp70 was significantly higher in 
the A group compared to both control groups (P<0.001 
for IC and P=0.007 for C). These differences disappeared 
at PD60 (Fig. 2C).
The expression level of phosphorylated mTOR 
was presented in Fig. 2D. Two‑way ANOVA confirmed 
Table I. Age‑related differences in the expression of proteins.
Control (C) Group Intubation Control (IC) Group Alcohol (A) Group
PD1‑PD10 PD10‑PD30 PD30‑PD60 PD1‑PD10 PD10‑PD30 PD30‑PD60 PD1‑PD10 PD10‑PD30 PD30‑PD60
iNOS p=0.750 ***p<0.001 ***p<0.001 p=0.500 ***p<0.001 p=0.194 **p=0.004 ***p<0.001 p=0.019
nNOS p=0.270 p=0.252 **p=0.004 p=0.575 **p=0.010 **p=0.013 p=0.735 p=0.316 ***p<0.001
HSP70 p=0.403 ***p<0.001 ***p<0.001 *p=0.016 ***p<0.001 **p=0.010 p=0.788 ***p<0.001 ***p<0.001
mTOR p=0.192 ***p<0.001 ***p<0.001 ***p<0.001 ***p<0.001 ***p<0.001 p=0.207 ***p<0.001 ***p<0.001
Bax ***p<0.001 p=0.593 *p=0.038 p=0.923 ***p=0.001 p=0.307 p=0.983 p=0.722 p=0.101
Bcl‑2 p=0.593 ***p<0.001 *p=0.030 p=0.874 **p=0.002 **p=0.005 p=0.943 **p=0.004 *p=0.014
Bax/Bcl‑2 p=0.298 ***p<0.001 p=0.273 p=0.512 ***p<0.001 p=0.408 p=0.520 ***p<0.001 p=0.195
Bcl‑XL *p=0.011 ***p<0.001 ***p<0.001 ***p<0.001 ***p<0.001 p=0.869 **p=0.004 ***p<0.001 ***p<0.001
PARP ***p<0.001 ***p<0.001 **p=0.005 ***p=0.001 p=0.777 p=0.436 p=0.120 p=0.202 p=0.057
PTEN ***p<0.001 ***p<0.001 p=0.355 ***p<0.001 ***p<0.001 p=0.908 ***p<0.001 ***p<0.001 **p=0.004
AKT ***p<0.001 p=0.509 ***p<0.001 ***p<0.001 **p=0.006 ***p<0.001 **p=0.001 p=0.164 ***p<0.001
GSK‑3α **p=0.010 ***p<0.001 ***p<0.001 *p=0.011 **p=0.005 ***p<0.001 ***p<0.001 ***p<0.001 ***p<0.001
GSK‑3β p=0.686 ***p<0.001 ***p<0.001 p=0.675 p=0.173 p=0.067 ***p<0.001 ***p=0.001 **p=0.006
ERK‑1 p=0.950 p=0.053 *p=0.014 p=0.774 p=0.524 p=0.830 *p=0.025 ***p<0.001 ***p<0.001
ERK2 p=0.145 ***p<0.001 ***p<0.001 ***p<0.001 **p=0.002 **p=0.007 ***p<0.001 ***p<0.001 ***p<0.001
JNK‑1 ***p<0.001 *p=0.019 p=0.663 ***p<0.001 p=0.223 p=0.518 ***p<0.001 ***p<0.001 p=0.170
JNK‑2 p=0.723 ***p<0.001 ***p<0.001 ***p<0.001 ***p<0.001 p=0.550 *p=0.037 ***p<0.001 ***p<0.001
p‑values refer to the difference between two consecutive age groups and are estimated by one‑way ANOVA followed by post hoc LSD test; *** for p≤0.001, ** for p≤0.01, and 
* for p≤0.05.
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a significant main effect of age on mTOR expression 
(F(3;35)=122.104, P<0.001), a significant main effect of 
treatment (F(2;35)= 31.562, P<0.001) and a significant age 
X treatment interaction (F(6;35)=13.228, P<0.001). Accord‑
ing to the post hoc analysis, a significant increase was 
observed in hippocampal mTOR concentration in all 
groups between the PD10–PD30 period, following a sig‑
nificant decrease in expression between PD30‑PD60 
(Table I). In the intubated groups, mTOR expression 
was lower on PD1 compared to the C group (P<0.001). 
At PD10 and PD30, it was still significantly lower in 
A group at PD10 and PD30 compared to both control 
groups (P<0.001). At PD60, the expression level of mTOR 
was higher in intubated groups compared to the intact 
control group, but was significant only for IC (P<0.001) 
(Fig. 2D). 
In order to investigate the effect of prenatal etha‑
nol intoxication and maternal stress on the Bcl‑2 fam‑
ily in rat hippocampus, we measured the expression 
of Bax (pro‑apoptotic) and Bcl‑2 (anti‑apoptotic) pro‑
teins and evaluated between‑group differences and 
age‑dependent changes in the Bax/Bcl‑2 ratio (Fig. 3A, 
B and C, respectively). A significant main effect of age 
(F(3;35)=17.005, P<0.001) and an age X treatment interac‑
tion (F(6;35)=5.142, P=0.002) with an insignificant treat‑
ment effect (F(2;35)=1.473, P=0.249) were revealed by 
Fig. 2. Prenatal ethanol consumption has an effect on neuroinflammation. Relative amounts of iNOS (A), nNOS (B), Hsp70 (C), and mTOR (D) proteins 
analyzed by western blot. Normalization for proteins was made with tubulin. The degree of significance was denoted as * for P≤0.05, ** P≤0.01, 
*** P≤0.001. Error bars indicate standard error of mean (SEM). 
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Fig. 3. Prenatal ethanol consumption affects apoptosis at adult age. Relative amounts of Bax (A), Bcl‑2 (B), the ratio of Bax to Bcl‑2 (C), Bcl‑XL (D), and the 
ratio of cleaved PARP89 to the full‑lenght PARP116 (E) proteins analyzed by western blot. Normalization for proteins was made with tubulin. The degree 
of significance was denoted as * for P≤0.05, ** P≤0.01, *** P≤0.001. Error bars indicate standard error of mean (SEM). 
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two‑way ANOVA for Bax expression. The two‑way ANO‑
VA for Bcl‑2 expression also revealed a significant main 
effect of age (F(3;35)=60.541, P<0.001), while treatment ef‑
fect and age X treatment interaction were rendered in‑
significant (F(2;35)=0.223, P=0.802 and F(6;35)=0.374, P=0.888, 
respectively). Two‑way ANOVA for the Bax/Bcl‑2 ratio 
revealed significant age (F(3;35)=154.363, P<0.001) and 
treatment (F(2;35)=4.516, P=0.022) effects with an insig‑
nificant age X treatment interaction. According to the 
pairwise comparison with post hoc LSD test, the expres‑
sion of Bax significantly decreased between PD1‑PD10 
in the C group (P=0.001) and between PD10‑PD30 in the 
IC group (P=0.001) with no age‑dependent changes in 
the A group (Table I). In contrast to this, the expression 
of Bcl‑2 significantly increased between PD10‑PD30 and 
PD30‑PD60 in all groups (P<0.001) (Table I). However, 
the expression of Bax in the A group did not change 
throughout the entire developmental period (Table I). 
Also, the Bax/Bcl‑2 ratio significantly decreased be‑
tween PD10‑PD30 (P<0.001) in all groups. While there 
was no significant between‑group difference in Bcl‑2 
expression, the expressions of both Bax and the Bax/
Fig. 4. Prenatal ethanol consumption affects cell survival through AKT pathway at birth. Relative amounts of (A) the ratio of phosphorylated PTEN to the 
total PTEN (pPTEN/PTEN), (B) the ratio of phosphorylated AKT to the total AKT (pAKT/AKT), (C) the ratio of phosphorylated GSK‑3α to the total GSK‑3α 
(pGSK‑3α /GSK‑3α), (D) the ratio of phosphorylated GSK‑3β to the total GSK‑3β (pGSK‑3β/GSK‑3β) proteins analyzed by western blot. Normalization for 
proteins was made with tubulin. The degree of significance was denoted as * for P≤0.05, ** P≤0.01, *** P≤0.001. Error bars indicate standard error of 
mean (SEM). 
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Bcl‑2 ratio were lower at PD1 in the IC and A groups 
compared to C group (P≤0.05) (Fig. 3A and C). The Bax/
Bcl‑2 ratio continued to be significantly lower in the 
A group compared to the C group at PD10 (P=0.023) 
(Fig. 3C). In addition, another Bcl‑2 family member, 
Bcl‑XL, also showed similar changes to Bcl‑2 during the 
study period, with a significant age effect (F(3;35)=244.785, 
P<0.001), treatment (F(2;35)=13.220, P<0.001) and age X 
treatment interaction (F(6;35)=10.254, P<0.001). Post hoc 
analysis showed that there was a significantly higher 
expression of Bcl‑XL protein in C group compared to 
both alcohol (P=0.004) and IC groups at PD30 and at 
PD60 (P<0.001) (Fig. 3D).
For the observation of cellular component disassem‑
bly, we also investigated the cleavage of PARP (the ratio 
of p89/p116), which serves as a marker of cells under‑
going apoptosis (Fig. 3E). The two‑way ANOVA for PARP 
expression demonstrated a significant main effect of 
age (F(3;35)=24.438, P<0.001), a significant main effect of 
treatment (F(2;35)=12.075, P<0.001) and a significant age X 
treatment interaction (F(6;35)=8.546, P<0.001). According 
to post hoc analysis, the ratio of cleaved PARP (p89) to 
Fig. 5. Prenatal ethanol consumption affects cell survival through ERK7JNK pathway at juvenile age. Relative amounts of (A) the ratio of phosphorylated 
ERK1 to the total ERK1 (pERK1/ERK1), (B) the ratio of phosphorylated ERK2 to the total ERK2 (pERK2/ERK2), (C) the ratio of phosphorylated JNK1 to 
the total JNK1 (pJNK1/JNK1), (D) the ratio of phosphorylated JNK2 to the total JNK2 (pJNK2/JNK2), (E) the ratio of phosphorylated CREB to the total 
CREB (pCREB/CREB) proteins analyzed by western blot. Normalization for proteins was made with tubulin. The degree of significance was denoted 
as * for P≤0.05, ** P≤0.01, *** P≤0.001. Error bars indicate standard error of mean (SEM). 
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full length PARP (p116) significantly increased during 
the PD1‑PD10 period (P≤0.001) and decreased during 
the PD10‑PD30 (P≤0.001) and PD30‑PD60 (P=0.005) pe‑
riods in the C group, while no significant change was 
noted in the A group throughout the entire 2‑months 
postnatal period (Table I). At PD10, the cleavage of 
PARP was significantly lower in the intubated groups 
compared to the C group (P≤0.05) (Fig. 3E).
A two‑way ANOVA done for the ratio of the phos‑
phorylated to the total PTEN revealed a significant 
main effect of age (F(3;35)=228.463, P≤0.001) and age 
X treatment interaction (F(6;35)=8.309, P<0.001) while 
the main effect of treatment remained insignificant 
(F(2;35)=2.767, P=0.083) (Fig. 4A). In all groups, activa‑
tion of PTEN increased between PD1‑PD10, to decrease 
in the following period between PD10‑PD30 (P≤0.001) 
(Table I). However, in the A group, a significant de‑
crease in pPTEN/PTEN ratio continued also between 
PD30‑PD60 (P=0.004). In the intubated A and IC groups, 
the activation of PTEN was significantly higher at 
PD1 (P=0.044 and P≤0.001, respectively) and at PD10 
(P=0.044 and P=0.017, respectively) compared to con‑
trol group. At PD30, the activation of PTEN was sig‑
nificantly lower in the IC group than in both C and A 
groups (Fig. 4A). 
In addition, two‑way ANOVA analysis evaluating be‑
tween‑group differences in phosphorylated AKT to to‑
tal AKT ratio, a protein that is related to cell survival, 
showed a significant age effect (F(3;35)=511.570, P≤0.001), 
treatment effect (F(2;35)=23.460, P<0.001) and age X treat‑
ment interaction (F(6;35)=47.318, P<0.001). As seen from 
Fig.4B and Table I, in all three groups, the ratio of 
pAKT/AKT showed an increase between the PD1‑PD10 
and PD30‑PD60 periods reaching the highest value at 
PD60. According to post hoc analysis, the value of pAKT/
AKT ratio was significantly higher in C group compared 
to A and IC groups at PD30, while at PD60, it became 
significantly higher in the A and IC groups than in the 
C group (P≤0.01) (Fig. 4B). 
Next, we found a significant main effect of age for 
phosphorylated GSK‑3α/total GSK‑3α (F(3;35)=110.897, 
P≤0.001) and for phosphorylated GSK‑3β/total GSK‑3β 
(F(3;35)=21.966, P≤0.001). For both ratios, there were also 
a significant main effect of treatment (F(2;35)=4.689, 
P=0.019, and F(2;35)=3.959, P=0.033, respectively) and 
a age X treatment interaction (F(6;35)=16.759, P<0.001, and 
F(6;35)=7.291, P<0.001, respectively). In all groups, the ac‑
tivation of GSK‑3α significantly decreased between the 
PD1‑PD10 and PD30‑PD60 periods and increased between 
the PD10‑PD30 period (P≤0.05) (Table I). Activation of 
the β subunit of GSK‑3 also significantly increased be‑
tween the PD10‑PD30 period and decreased between the 
PD30‑PD60 period (P≤0.05). In the A group, the expres‑
sion of both GSK‑3α and GSK‑3β was significantly higher 
at PD1 compared to both control groups (P≤0.001), and 
expression of GSK‑3β in the A group was significantly 
lower at PD10 compared to IC group (P=0.012) (Fig. 4C 
and D). At PD30, a significant decrease in the expression 
of both GSK‑3α and GSK‑3β was observed in the intu‑
bated groups as compared to the C group (P≤0.05). No 
significant between‑group differences were observed at 
PD60 for either GSK‑3α or GSK‑3β.
In the present study, the extracellular signal‑regu‑
lated kinase (ERK) family members ERK1 and ERK2 un‑
derwent similar changes with age. A two‑way ANOVA 
applied to these data revealed in both cases a significant 
effect of age (F(3;35)=10.792, P≤0.001 and F(3;35)=136.315, 
P≤0.001, respectively), significant treatment effect 
(F(2;35)=5.705, P=0.009, and F(2;35)=64.916, P≤0.001, respec‑
tively) and significant age X treatment interaction 
(F(6;35)=6.930, P<0.001, and F(6;35)=35.044, P<0.001, respec‑
tively) (Fig. 5A and 5B). Post hoc analysis confirmed 
a significant decrease in the activation of ERK1/2 be‑
tween PD30‑PD60 in the C group (P=0.014 and P≤0.001, 
respectively). However, ethanol treatment significant‑
ly changed the activation pattern of ERK1/2 during all 
studied time periods (Table I). At PD1, the phosphor‑
ylation ratio of ERK2 was significantly higher in intu‑
bated groups compared to control group (P≤0.001). In 
the A group, the ratio of pERK1/2 to total ERK1/2 was 
significantly higher at PD30 compared to both control 
groups (P≤0.001) and at PD60 compared to the C group 
(Fig. 5A and B).
Fig. 5C and 5D show changes in the phosphorylation 
ratio of c‑Jun N‑terminal kinase (JNK)1 and JNK2 in all 
three groups, throughout the two postnatal months. 
A two‑way ANOVA analysis of pJNK1/JNK1 and pJNK2/
JNK2 ratios confirmed for both proteins a signifi‑
cant age effect (F(3;35)=66.282, P≤0.001 and F(3;35)=86.162, 
P≤0.001, respectively), treatment effect (F(2;35)=9.132, 
P=0.001, and F(2;35)=30.631, P≤0.001, respectively) and 
age X treatment interaction (F(6;35)=7.113, P<0.001, and 
F(6;35)=34.550, P<0.001, respectively). Post hoc analysis re‑
vealed a significant increase in the activation of JNK1 
between PD1‑PD10 and in the activation of JNK2 be‑
tween PD10‑PD30 in C group (P≤0.001) which was fol‑
lowed by a decrease in the relative phosphorylation of 
JNK2 but not JNK1 in this group (Table I). Nevertheless, 
on PD30 and PD60, activation of JNK1 was significant‑
ly lower in the intact control (C group) compared to 
both IC and A groups (P≤0.05). However, in the A group, 
the ratios of phosphorylation of JNK1/2 significantly 
decreased compared to the IC group at PD10 (P=0.043 
and P≤0.001, respectively). Relative phosphorylation 
of JNK2 was significantly higher in IC on PD10 and 
PD60 compared to both C and A groups (P≤0.001) and 
in A group on PD30 compared to both C and IC groups 
(P≤0.001). (Fig. 5C and D).
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DISCUSSION
According to the previous studies by us and other 
authors, the adverse effects of fetal ethanol exposure 
and/or maternal stress observed either on behavioral, 
morphological, or molecular level tend to be more pro‑
nounced in juvenile subjects than in adult animals. This 
fact points either towards an ethanol‑ or a stressor‑in‑
duced developmental delay or a recovery from etha‑
nol‑induced impairments due to some regeneration 
process. Therefore, in the present study, we investigat‑
ed hippocampal expression/activation of some regu‑
latory proteins that may potentially contribute either 
to the damage of the developing nervous system or to 
the recovery from the damage produced by the adverse 
external factors, here, fetal‑ethanol exposure and ma‑
ternal stress. 
Since it has been previously reported that prenatal 
ethanol exposure among other multiple effects may 
also cause neuro‑inflammation (Tiwari and Chopra, 
2011; Komada et al., 2017), we included to the present 
study iNOS, and Hsp70 proteins known as inflammato‑
ry markers (Feldman et al., 1993; Borges et al., 2012). 
For comparison, we also examined nNOS levels. iNOS 
expression in the intact subjects (C group) underwent 
a fluctuation during the two‑months postnatal period: 
low during the first 10 postnatal days, highly increased 
at the juvenile age (PD30) to decline in the young adults 
(PD60). Interestingly, at PD1, fetal ethanol exposure 
resulted in the elevated iNOS values which, however, 
dropped to the normal level already at PD10. High iNOS 
levels at birth overlapped with deficits in hippocampal 
neurons morphology which, however, disappeared by 
PD10 (Jakubowska‑Doğru et al., 2017). Increased level of 
iNOS at PD1 is consistent with a previous study by Dizon 
and colleagues (2004) who also observed in the brains 
of newborn guinea pigs a transient increase in the con‑
centration of iNOS. Parallel to this, previous studies by 
Blanco and colleagues (2004) showed that short‑term 
ethanol treatment may up‑regulate iNOS expression 
in the cortical astrocytes culture; the effect regulated 
via nuclear factor kappa B (NF‑κB). Relatively low iNOS 
levels at PD30 in intubated groups were paralleled by 
elevated nNOS expression in pups exposed to the ma‑
ternal stress per se. High iNOS level observed again in 
young adults from intubated groups is consistent with 
previous reports showing enhanced expression of mi‑
croglial activation markers in the hippocampus of the 
adult prenatally stressed animals (Slusarczyk et al., 
2015). The other NO producer, nNOS, which has a role in 
CNS development was affected by maternal intubation 
stress at PD30. During postnatal development, in all 
three groups, the highest amount of nNOS expression 
was noted at the adult age. Generally, nNOS expression 
in this study was very little affected by the applied 
treatments. According to the literature, NOS enzymes 
and their product NO may act as a double‑edge sward, 
on the one hand mediating inflammation and apopto‑
sis, on the other hand, showing some neuroprotective 
effects. The neuroprotective effect of NO were previ‑
ously reported in the nervous system developing under 
ethanol intoxication (Chandler et al., 1997; de Licona et 
al., 2009). Bonthius and colleagues (2002) demonstrat‑
ed that prolonged ethanol exposure enhanced NMDA 
receptor‑stimulated NO formation followed by acti‑
vation of cGMP‑PKG pathway and an increase of neu‑
rons survival. On the other hand, decreased levels of 
nNOS expression were found to exacerbate brain injury 
by restricting brain growth after prenatal ethanol ex‑
posure (Kimura and Brien, 1998; Karacay et al., 2015). 
Looking at our results, we can speculate that prenatal 
ethanol administration may have compromised NO sig‑
naling in the hippocampus and led to a compensation 
mechanism by reversing NO signaling effect upon etha‑
nol withdrawal at birth in the form of a quick recovery 
from morphological deficits.
In the intact group, during a transition period from 
infancy to the juvenile age (PD10‑PD30), it was observed 
a significant increase in the hippocampal expression of 
heat shock protein 70 (Hsp70), one of highly conserved 
stress proteins which through inhibiting components 
of inflammatory signaling pathways, such as the NF‑κB 
transcription factor, may also have an anti‑inflamma‑
tory effect in organism’s immune responses (Borges 
et al., 2012). The hippocampal concentration of Hsp70, 
showed a significant increase in IC group at PD10 and in 
A group at PD30. Previously, an increased level of hip‑
pocampal Hsp70 was found to be associated with dura‑
tion of maternal ethanol consumption (Holownia et al., 
1995). Hsp70 was also increased in neuronal cells under 
some other pathological conditions such as trauma, 
ischemia or seizures (Lemoine et al., 2003). We found 
that prenatal intubation stress affects Hsp70 expres‑
sion at the brain growth spurt period. Previous in vitro 
studies indicated that stress rapidly increased the ex‑
pression of heat shock proteins (Lallemandmezger et 
al., 1993), which can be produced by non‑neuronal cells 
(Walker and Carlock, 1993).
The mammalian target of rapamycin (mTOR) path‑
way also regulates the NO system, producing both 
pro‑inflammatory and anti‑inflammatory effects (We‑
ichhart et al., 2015). In the intact control group, the ex‑
pression of mTOR significantly increased through the 
developmental PD1‑ PD30 period to drop at young adult 
age. This remains in line with a previous report by oth‑
er authors who also observed changes in mTOR level 
with age (Choi et al., 2016). The relatively low level of 
mTOR at birth in intubated groups might be related 
Prenatal ethanol intoxication and cell survival 143Acta Neurobiol Exp 2019, 79: 133–147
to the disruptive effect of prenatal stress and ethanol 
administration on the role of mTOR in the process of 
neuronal and glial differentiation during the third tri‑
mester (Lee, 2015). The mTOR level continued to be sig‑
nificantly lower in the fetal‑ethanol pups throughout 
the whole brain spurt period when an intensive neu‑
rogenesis and cell growth still take place. This may be 
one of the factors contributing to a decreased count of 
granular cells in the gyrus dentatus in the fetal‑etha‑
nol group at PD30 (Jakubowska‑Doğru et al., 2017). In A 
group, the mTOR expression reached its normal level at 
juvenile age while in IC group, a compensatory increase 
in mTOR concentration was recorded from juvenile age 
to the adulthood. However, the effect of maternal stress 
was observed as a significant increase in the mTOR ex‑
pression at PD30 and PD60, supporting a role for mTOR 
in controlling the cell growth and metabolism in re‑
sponse to stress (Hall, 2008). 
Previous studies showed that ethanol‑induced 
mTOR activation may occur through the AKT‑mTOR 
signaling pathway (Fu et al., 2016). The main functions 
of AKT downstream pathways are promoting cell pro‑
liferation, growth, and motility (migration) as well as 
regulation of apoptosis. According to the literature, 
effect of ethanol administration on AKT activation de‑
pends on the ethanol dose and the type of cells. Acute 
systemic administration of alcohol resulted in activa‑
tion of AKT in the rodent nucleus accumbens (Neasta et 
al., 2011) while an inhibition of PI3K/AKT signaling by 
ethanol was recorded in primary cortical neurons (Liu 
et al., 2010). In our study, in the intact rat pups, a sig‑
nificant increase in phosphorylated AKT was observed 
between PD1‑PD10 and PD30‑PD60., while it was stable 
at PD10‑PD30. Until PD30, ethanol administration de‑
creased activation of AKT, in line with the previously 
described negative effect of alcohol on the survival of 
neurons, which may be attributable to this pathway 
(Akbar et al., 2006). Both maternal stress and prena‑
tal ethanol exposure resulted in a significant increase 
in the amount of phosphorylated AKT in young adults 
when the neurodevelopmental processes were about 
to be completed. Apparently, prenatal ethanol did not 
affect activation of AKT during a critical first postna‑
tal month. A transient decrease in AKT activity was 
observed only in juveniles exposed to maternal stress. 
A reduction in AKT activation was also observed in pre‑
natally stressed animals at PD30 (Jia et al., 2016). 
To better understand how prenatal stress and eth‑
anol exposure affected the PI3K‑AKT‑mTOR signaling, 
we also investigated the activity of PTEN, the upstream 
effector and regulator molecule of AKT (Tseng et al., 
2012). As expected, changes in the activation of PTEN 
and AKT were generally in the opposite directions: at 
birth, high activation of PTEN corresponded to rel‑
atively low AKT activation, and a relatively low acti‑
vation of PTEN in young adults corresponds to high 
AKT activation. Significantly higher activation of PTEN 
and very low activation levels of both AKT and mTOR 
at PD1 in pups exposed to fetal ethanol and/or ma‑
ternal stress corresponded to the deficiencies in mor‑
phological development in the hippocampal neurons 
(Jakubowska‑Doğru et al., 2017). However, at the end of 
brain spurt period (PD10), when we already observed 
a normalization of the morphological parameters in 
hippocampal neuron, a burst in PTEN activation espe‑
cially pronounced in IC and A groups was noted. It was 
accompanied by a small increase in the AKT activation. 
This is weakening a possibility that PI3K‑AKT‑mTOR 
signaling pathway contributes to the recovery from the 
morphological deficits caused by gestational ethanol 
and/or stress. A decrease in PTEN activation was ob‑
served through PD10‑PD60 period with a burst in AKT 
activity at PD60 which was significantly bigger in IC 
and A groups compared to the intact control. 
GSK3, another downstream molecule of PI3K‑AKT‑
‑mTOR pathway, is also essential for neuroprotection. 
As seen from our results, treatment‑ and age‑depen‑
dent activation of GSK‑3α and GSK‑3β, two isoforms of 
GSK3, are highly similar. GSK3 is constitutively active, 
but its activity can be inhibited by phosphorylation 
on Ser21 of GSK3α and Ser9 of GSK3β. GSK3 substrates 
negatively regulated by GSK3‑mediated phosphoryla‑
tion are involved in cell fate determination and prolif‑
eration, while substrates positively regulated by GSK3 
are more involved in cell differentiation and functions 
controlling such neuronal processes as neurite out‑
growth, synapse formation, and neurotransmission 
(Cole, 2012). According to the presented data, during 
normal development, both GSK‑3α and GSK‑3β reached 
peak levels at PD30. However, fetal ethanol exposure 
disrupted this pattern by an increase in the activity 
of both GSK‑3 subunits at birth. Activation of AKT by 
ethanol in the present study caused phosphorylation of 
GSK‑3β, which inactivates it (Cole, 2012). There is also 
an evidence that chronic fetal exposure to ethanol in‑
duces a dephosphorylation of GSK3β and increases its 
activity (Xu et al., 2003). This reduction in GSK‑3 activ‑
ity may be a compensatory mechanism for attenuation 
of axonal degeneration, as suggested in previous stud‑
ies (Muyllaert et al., 2008). At PD30, a decrease in the 
phosphorylation of GSK‑3 by ethanol paralleled a de‑
crease in AKT phosphorylation. Apparently, gestational 
maternal stress did not have such an effect. However, at 
PD10, the significant increase in GSK‑3 activity due to 
the decrease in phosphorylation was independent from 
AKT phosphorylation by ethanol. Increase in GSK3 ac‑
tivity during brain spurt period may contribute to a re‑
covery from fetal ethanol‑ and maternal stress‑induced 
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delay in morphological development of hippocampal 
neurons (Jakubowska‑Doğru et al., 2017). In contrast, it 
was reported that ethanol‑dependent dephosphoryla‑
tion of GSK‑3 causes ROS production and activation of 
Bax as well as caspase‑3 in developing mouse brain (Liu 
et al., 2009; Luo, 2014). 
PTEN also controls phosphorylation and activation 
of ERK1/2 pathways by deactivating these pathways via 
downstream effectors (Gu et al., 1998; Ning et al., 2004). 
ERK pathways were shown to be involved in many pro‑
cesses in the nervous system including development 
by affecting cell proliferation, differentiation, adhe‑
sion, migration and survival but also apoptosis which 
plays an important role during neural development 
(Alessandrini et al., 1999; Irving and Bamford 2002). In 
the present study, under fetal ethanol intoxication, an 
increase in ERK1 activation was observed around the 
second postnatal month while in ERK2 almost through 
the whole postnatal period followed. At PD30, activa‑
tion of ERK1/2 reached a peak value. Prenatal stress 
affected activation of ERK2 only, with the greatest in‑
crease at birth. Previously, in contrast to our findings, 
prenatal acute and chronic ethanol administration in 
mice was shown to inhibit ERK expression and activa‑
tion in thalamus and cerebral cortex (Kalluri and Ticku, 
2002; Mooney and Miller, 2011). Deficit in NMDA recep‑
tor‑dependent ERK1/2 activation was also reported in 
the dentate gyrus of adult C57BL/6J mice prenatally 
exposed to ethanol (Samudio‑Ruiz et al., 2009). There is 
also an evidence that acute ethanol in binge‑like drink‑
ing model may increase pERK1/2 activity compared to 
a vehicle control in brain regions known to control ad‑
dictive behaviors and drug self‑administration (Agoglia 
et al., 2015). ERK1/2 plays a pivotal role as a signaling 
molecule for differentiation of progenitor cells (Sam‑
uels et al., 2008). In our previous studies, at PD30, we 
observed a reduction in the number of granular cells 
(Elibol‑Can et al., 2014a) and in NeuN protein expres‑
sion (unpublished data) in hippocampus due to pre‑
natal ethanol exposure. On the other hand, a drop in 
ERK1/2 (especially ERK2) activity at PD60 correspond‑
ed to the morphological and functional recovery (Eli‑
bol‑Can et al., 2014a). Therefore, a significant increase 
in ERK1/2 activation in juvenile fetal alcohol pups may 
be the result of a compensatory mechanism against the 
reduction of neuronal differentiation in the hippocam‑
pus. The above mentioned discrepancies in the results 
may partially arise from the differences in the dose, 
timing, and the route of ethanol administration as well 
as animal species, brain region under examination, and 
timing of biochemical assays.
In addition to ERK1/2, the regulation of JNK1/2, 
another mitogen activated kinase (MAPK), is essential 
for neuroprotection against substance‑induced neuro‑
toxicity (Yuan et al., 2017). As it was observed in the 
case of ERK1/2, the activation of JNK1/2 also signifi‑
cantly increased at PD30 through PD60. Interesting‑
ly, in the IC group, an increase in JNK1/2 also referred 
to as stress‑activated kinases was highly pronounced 
through the extended period between PD10 and PD60. 
Previous studies have shown an enhancing effect of eth‑
anol on the phosphorylation of the proteins found in 
the MAPK pathway, including ERK1/2 and JNK1/2 (Zhao 
et al., 2015; Wang et al., 2017). Similarly to ERKs, upon 
activation, JNKs may phosphorylate and activate nucle‑
ar transcription factors to initiate neuronal regenera‑
tive mechanisms and apoptosis (Cavigelli et al., 1995; Xu 
et al., 1997). There is a notion that a parallel activation 
of the ERK1/2, just as it is in the present study, may op‑
pose the apoptosis‑inducing JNK activation both in vitro 
and in vivo (Xia et al., 1995; Xu et al., 1997).
Since the programmed cell death (apoptosis) during 
brain development is an important homeostatic mecha‑
nism adjusting the pool of progenitor cells required for 
proper morphogenesis of the nervous system and ad‑
justing neuron populations to match their target fields 
(Kuan et al., 2000), it is not surprising that the highest 
expression of pro‑apoptotic Bax protein and the high‑
est ratio of Bax to anti‑apoptotic Bcl‑2 was recorded 
during the first 10 postnatal days (human 3rd trimester 
equivalent covering the brain growth spurt period). On 
the contrary, the highest levels of anti‑apoptotic pro‑
teins such as Bcl2 and Bcl‑XL were found during the 
second postnatal month when development has been 
largely completed. There is a great number of in vivo, 
ex vivo and in vitro studies suggesting that ethanol pro‑
motes apoptotic cell death in neural tissues and gives 
rise to the observed neuropathologies and behavioral 
impairments (Freund, 1994; Cartwright et al., 1998; de 
la Monte et al., 2000; Ikonomidou et al., 2000; Heaton et 
al., 2003; Luo, 2012) by affecting Bcl‑2 family proteins 
(Ge et al., 2004; Heaton et al., 2011). The adverse effects 
of gestational ethanol intoxication and stress can be 
long‑lasting showing up in different forms at differ‑
ent postnatal ages. One of such effects is an increased 
apoptosis and excessive loss of neurons. In our previ‑
ous studies (Elibol‑Can et al., 2014a), under the same 
experimental paradigm, we observed a transient de‑
crease in the hippocampal neuron count at PD30. In the 
present study, however, both prenatal ethanol exposure 
and maternal intubation stress showed damping effect 
on the expression of apoptotic markers decreasing the 
Bax/Bcl‑2 ratio. Inactivation of PARP‑1, another death 
promoter molecule that senses DNA damage and its ac‑
tivity is quantifiable by subsequent increased cleavage 
of full length PARP‑1 to its respective 89 kDa fragment, 
is also a hallmark of apoptosis (Soldani and Scovassi, 
2002; Kim et al., 2005; Cherian et al., 2008). The peak of 
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PARP89/PARP116 in intact control was reached at PD10 
and it was significantly higher than the values of this 
ratio in IC and A groups confirming the results of Bax/
Bcl2 evaluation. Prenatal ethanol exposure disrupted 
the age‑dependent change in PARP cleavage during the 
studied period, as suggested previously (Ramachan‑
dran et al., 2001; Cherian et al., 2008). 
If not apoptosis, another reason of a decrease in 
neuron counts due to ethanol intoxication may be 
a slowed down proliferation of neural progenitor cells 
(Jacobs and Miller, 2001). In our study, this notion finds 
support in decreased levels of AKT, mTOR, and GSK‑3 
enzymes during the first postnatal month. All three en‑
zymes are known as positive regulators of neurogenesis 
(Yu and Cui, 2016).
CONCLUSION
In summary, during the postnatal development, 
a wide range of changes in expression and activation 
profiles of proteins related to inflammation, cell sur‑
vival and apoptosis was observed in fetal ethanol‑ and/
or maternal stress‑ exposed rat pups. During the early 
postnatal period (PD1‑PD10), in the treatment groups, 
it was seen an upregulation of proteins such as iNOS, 
Hsp, PTEN, GSP‑3, ERK and JNK having apart from mul‑
tiple other functions pro‑inflammatory and pro‑apop‑
totic effects. Interestingly, GSK3 activity and iNOS ex‑
pression were more affected by fetal ethanol than the 
maternal stress. Despite of this, apoptotic indices Bax/
Bcl2 and PARP cleavage were significantly decreased 
during the critical brain growth spurt period in both 
IC and A pups. It indicates that the recovery process 
in A and IC brains started soon after the birth upon 
the ethanol and stressor withdrawal. It is reflected by 
a fast upregulation of morphological features in the 
hippocampal neurons observed at PD10 in our previ‑
ous study (Jakubowska et al., 2017). A significant in‑
crease in the activity of survival‑related AKT pathway 
in A and IC groups during the second postnatal month 
shows that neural development and the compensatory 
processes continue until the adulthood. Indeed, these 
data together with our previous findings confirm that 
developmental shaping of the hippocampus at both the 
cellular and molecular level continues through the ju‑
venile age or even longer.
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